Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Functional assays for BRCA1 and BRCA2.

Marcelo A Carvalho1, Fergus J Couch, Alvaro N A Monteiro

  • 1Department of Risk Assessment, Detection, and Intervention, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA.

The International Journal of Biochemistry & Cell Biology
|September 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Updated ENIGMA recommendations for reporting germline variants in cancer susceptibility genes and their translation into twenty languages.

Journal of medical genetics·2026
Same author

Mutagenesis of the PALB2 WD40 domain identifies variants defective in interaction with BRCA2 and DNA repair.

The Journal of biological chemistry·2025
Same author

Functional evaluation and clinical classification of BRCA2 variants.

Nature·2025
Same author

SART1 modulates poly-(ADP-ribose) chain accumulation and PARP1 chromatin localization.

iScience·2024
Same author

Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing.

NPJ precision oncology·2024
Same author

BRCA1 frameshift variants leading to extended incorrect protein C termini.

HGG advances·2024
Same journal

Corrigendum to "Sodium butyrate down-regulation of indoleamine 2, 3-dioxygenase at the transcriptional and post-transcriptional levels" [Int. J. Biochem. Cell Biol. 42 (2010) 1840-1846].

The international journal of biochemistry & cell biology·2026
Same journal

Whole-brain spatial metabolomics reveals metabolic gradient shifts in a murine glioma model following boron neutron capture therapy (130 characters).

The international journal of biochemistry & cell biology·2026
Same journal

LCN2 modulates Th17/Treg balance in vitro and is associated with an adaptive response to intestinal ischemia-reperfusion injury under Hmox1-deficient conditions.

The international journal of biochemistry & cell biology·2026
Same journal

Chloroquine modulates the redox-sensitive signalling via inhibiting the AMPK-ULK1 under LPS induced state in murine splenic macrophages.

The international journal of biochemistry & cell biology·2026
Same journal

The vicious cycle of hyperglycemia and oxidative stress: Novel mechanistic insights into a pathogenic alliance.

The international journal of biochemistry & cell biology·2026
Same journal

Fibroblast growth factors (FGF) in the pathogenesis and treatment of inflammatory bowel diseases (IBD): An overview.

The international journal of biochemistry & cell biology·2026
See all related articles

Genetic testing for breast cancer genes like BRCA1 and BRCA2 has limitations. Functional assays using biochemistry and cell biology can improve the interpretation of missense mutations, enhancing cancer risk assessment.

Area of Science:

  • Genetics
  • Biochemistry
  • Cell Biology

Background:

  • Genetic testing for breast cancer susceptibility genes (BRCA1, BRCA2) is widely available.
  • Current genetic tests face challenges with sensitivity and specificity, particularly in classifying missense mutations.
  • Distinguishing cancer-predisposing mutations from neutral variants in genes like BRCA1, BRCA2, ATM, and MSH2 remains difficult.

Purpose of the Study:

  • To address the limitations in interpreting genetic test results for cancer susceptibility genes.
  • To explore the application of biochemistry and cell biology in clarifying the clinical significance of missense mutations.
  • To advocate for the use of functional assays to complement genetic data for unclassified missense mutations.

Main Methods:

  • Focus on the interpretation of genetic test results for BRCA1 and BRCA2.

Related Experiment Videos

  • Utilize principles of biochemistry and cell biology to analyze missense mutations.
  • Propose the development and implementation of functional assays.

    • Main Results:

    • Current genetic testing struggles to accurately determine the pathogenicity of numerous identified missense mutations.
    • Biochemistry and cell biology offer valuable tools to elucidate the functional impact of these mutations.
    • Functional assays can provide crucial data to resolve ambiguities in genetic test interpretations.

    Conclusions:

    • Functional assays are essential to complement genetic data for classifying uncertain missense mutations in cancer susceptibility genes.
    • Standardized protocols for conducting and interpreting functional assays are needed.
    • Improved interpretation of genetic variants will enhance cancer risk assessment and clinical management.